Showing results (101-110 of 315) with videos related to

Sort By:
Pageof 32
Pathophysiology of Haemostasis and Thrombosis|October 10, 2002
Hemostasis and fibrinolysis factors in first-degree relatives of patients with Type 2 diabetes without hypertensionA Trifiletti, A Lasco, R Scamardi, et al.
Pathophysiology of Haemostasis and Thrombosis|October 10, 2002
Abnormally short activated partial thromboplastin times are related to elevated plasma levels of TAT, F1+2, D-dimer and FVIII:CEdwin Ten Boekel, Piet Bartels
Pathophysiology of Haemostasis and Thrombosis|March 12, 2008
Effects of pitavastatin on adiponectin in patients with hyperlipidemiaN Inami, S Nomura, A Shouzu, et al.
Pathophysiology of Haemostasis and Thrombosis|June 18, 2003
Argatroban in HIT type II and acute coronary syndromeBruce E Lewis, Jeanine M Walenga
Pathophysiology of Haemostasis and Thrombosis|June 18, 2003
Practical issues in the development of argatroban: a perspectiveJawed Fareed, Debra Hoppensteadt, Omer Iqbal, et al.
Pathophysiology of Haemostasis and Thrombosis|September 19, 2003
Venous thrombosis: the history of knowledgeP M Mannucci
Pathophysiology of Haemostasis and Thrombosis|September 19, 2003
Glanzmann thrombasthenia: a model disease which paved the way to powerful therapeutic agentsUri Seligsohn
Pathophysiology of Haemostasis and Thrombosis|September 19, 2003
Biochemistry and clinical pharmacology of new anticoagulant agentsMeyer Michel Samama, Grigoris T Gerotziafas, Ismail Elalamy, et al.
Pathophysiology of Haemostasis and Thrombosis|September 19, 2003
Inherited abnormalities in the protein C activation pathwayFrancisco España, Pilar Medina, Silvia Navarro, et al.
Pathophysiology of Haemostasis and Thrombosis|September 19, 2003
The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulabilityH C Hemker, P Giesen, R AlDieri, et al.
Pageof 32